The A3243G mitochondrial mutation is the major cause of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). The severity of the disease is correlated with the heteroplasmy level of the mutation. Here we describe for the first time the validation of a real-time polymerase chain reaction (PCR) assay with Taqman locked nucleic acid (LNA) fluorescent (FAM for mutant, HEX for wild type) probes for quantification of heteroplasmy levels in a total of 18 family members from 5 Vietnamese MELAS patients carrying A3243G. Almost no background of FAM signals was detected in normal samples, indicating that the probes were allele-specific. Standard curves indicate sensitive detection at 0.1% mutants and high reliability with R 2 > 0.985. The correlation line between measured % mutant and expected % mutant was highly reliable, with a slope of 0.993 and R 2 of 0.998. All positive A3243G mutant samples pre-screened by PCR-restriction fragment length polymorphism (RFLP) were confirmed, and their heteroplasmy levels quantified to be from 3.68 to 80.85%. The heteroplasmy levels in patients were higher than in their family members and generally correlated well with the severity of their clinical symptoms. Overall, this work is the first demonstration of the application of LNA probes for sensitive and highly reliable quantification of heteroplasmy levels in human mitochondria.
Introduction
The A3243G mutation in the mitochondrial genome is considered to have the highest frequency of mitochondrial diseases [1] . This mutation is in the gene encoding tRNA Leu and is the main cause of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes, (MELAS) [2, 3] . The A3243G mutation exists in heteroplasmy, with cells having both wild-type and mutant mitochondrial DNA (mtDNA). The heteroplasmy level is an important factor affecting the phenotype and severity of the disease. The rate of mitochondrial mutations is the main cause of the creation of the threshold heteroplasmy level at which clinical symptoms are shown [2] . Therefore, the detection and quantification of A3243G mutation copies is a critically important molecular basis for the accurate diagnosis of MELAS caused by mutations.
Different approaches have been developed to quantify the heteroplasmy level of A3243G mitochondrial mutations. Most of them are time-consuming, such as polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), followed by ethidium bromide or silver staining [4, 5] , pyrosequencing [6] , and ligation mediated PCR [7] . Real-time PCR is a rapid, sensitive, and accurate technique of allelespecific quantification that can be applied in diagnostic laboratories in hospitals [8] . Singh and his colleagues have developed a real-time PCR to simultaneously detect and quantify A3243G mutation in MELAS patients with fluorescent probes (FAM, VIC) conjugated with minor groove binder protein (MGB) that provide sensitivity down to 0.1% mutant [9] . To date, the ABI-licensed Taqman-MGB probes have been well established to quantify heteroplasmy levels in mitochondria, probably because the non-fluorescent MGB quencher exhibits greater differences in T m values between matched and mismatched probes, thus providing more accurate allelic discrimination than other conventional fluorescent quencher probes [10] [11] [12] . In this study, we applied an alternative locked nucleic acid (LNA) probe technology to quantify the heteroplasmy level of A3243G mutation in mitochondrial (mt) DNA. The method was developed and validated with a sensitivity of 0.1% to quantify the heteroplasmy levels of 18 family members of five patients with MELAS carrying A3243G mutation. This work is the first demonstration of the use of Taqman LNA probes as an alternative to MGB probes for sensitive and highly reliable quantification of heteroplasmy levels in human mitochondria.
Materials and methods

Samples
Blood specimens from 106 patients with symptoms suggestive of encephalomyopathy (including myopathy, locomotor ataxia, elevated lactate content in plasma or cerebrospinal fluid, and abnormal brain magnetic resonance imaging) and family members of five patients carrying A3243G mutations were collected at the National Hospital for Pediatrics (NHP), according to the guidelines and ethical rules of the NHP. All the patients and their family members signed a consent form for volunteer participation in the research. Among 106 patients, only 5 patients had clear clinical symptoms of MELAS, whereas the other patients had symptoms suggestive of encephalomyopathy or clinical symptoms of other syndromes.
DNA isolation and detection of A3243G mutation using PCR-RFLP
The total DNA from blood samples was isolated by use of the QIAamp DNA Mini kit (Qiagen, USA) and spectrophotometrically quantified by NanoDrop ND-1000 (NanoDrop, USA). In order to detect the A3243G in the mitochondrial genome, an mtDNA fragment of 198 bp (3134-3331) was amplified with A3243G Fw: 5' CAA GAG AAA TAA GGC TTA CTT C 3' (3134-3155) and A3243G Rv: 5'GGA GTA GGA GGT TAG CCA TGG G 3' (3310-3331) primers on the basis of the reference sequence of Trinh et al. [13] . The mismatched nucleotides (underlined) were intentionally included in the primers to remove an HaeIII recognition and cutting site in the primer region. PCR products were digested with HaeIII and separated by 10% polyacrylamide nondenaturing gel electrophoresis in 1 x TBE buffer, pH 8.0, followed by ethidium bromide staining, visualized and photographed by Geldoc (Biorad, USA). The amplified mutant mtDNA fragment showed two bands of 111 bp and 87 bp after HaeIII digestion, whereas the amplified wild type mtDNA fragment showed only one band of 198 bp. PCR products were also cloned into pGEM-T and transferred into DH5α E. coli cells. Recombinant plasmids were isolated and used for sequencing to check for the presence of the mutation with the CEQ 8000 system (Beckman Coulter, USA).
Development of real-time PCR assay using LNA probes
Quantitative measurement of the A3243G heteroplasmy level by Taqman real-time PCR was performed with primers and fluorescent labelled oligo-probes (purchased from IDT Inc., USA); their sequences and melting temperatures (T m ) are presented in Table 1 . Probes were labelled at the 5' end with 6-FAM reporter for the mutant and HEX reporter for the wild type, and they were labelled at the 3' end with IBFQ (quencher) for both wild-type and mutant. The Mt-LNA-FAM-1 was designed to have one "locked" nucleotide at the mutant position, and the Wt-LNA-HEX-1 was designed to have two "locked" nucleotides at the mutant and its neighbouring positions, so that T m values of the two probes were close and higher than the T m of primers (see details in Table 1 ). Non-LNA probes including Mt-FAM-2 and Wt-HEX-2 having the same oligo-sequence, but without "locked" nucleotides, were used for a parallel comparison. The sensitivity of the assays was validated by two types of standards, including individual wild-types and individual mutants at six standard concentrations ranging from 5 x 10 2 to 5 x 10 7 copies/ml and sample mixtures of mutants and wild types at five different ratios (0.01%, 0.1%, 1%, 10%, 50% to 100%). Real-time PCR was run at conditions of 95°C for 10 s, 40 cycles at 95°C for 15 s, and at 60°C for 60 s in an iQ5 cycler (Biorad, USA). The C t values (threshold cycles) were calculated on the basis of an amplification chart and the standard curves with R 2 value showed correlation between the copy number of plasmids and measured C t values. The actual average % mutant value was calculated based on triplicate measurement of the copy number of mutant and wild type in each sample mixture.
Allele-specific relative quantification of
A3243G mutation
The copy numbers of mutants and wild-types in the patient samples were calculated based on the standard lines built on C t values (y axis) vs the copy number of six standards (x axis). The standards were mixtures at a 1:1 ratio of plasmids pGEM-m.A3243G and pGEM-w.A3243 at increasing concentrations from 10 3 to 10 8 copies/ml. The measurement was performed in triplicate, and data were statistically analysed. The level of heteroplasmy was defined as the percentage of mutant copies per total copies of mutant and wild type.
Results
Detection of A3243G mutation in five family members
After screening 15 point mutations in mtDNA of 106 pediatric patients in Vietnam, we found 6 cases (4 males and 2 females, 5.7% of total cases) of A3243G mutation. As A3243G has been proven to be maternally inherited, we further analyzed specimens from five family members of patients with A3243G mutations.
PCR products from 18 samples after digestion by HaeIII had different DNA fingerprints, as shown in Figure 1A . All patients (abbreviation: P), their brothers (B), and their mothers (M) carried the A3243G mutation, as shown by the presence of 111 bp and 87 bp bands, whereas the fathers (F) had only one band of 198 bp, suggesting they did not carry the A3243G mutation. We could not find the mutation in the samples of their aunts (A) and an uncle (U). The presence of 198 bp bands in samples of patients (P), brothers (B), and mothers (M) ( Figure 1A : lane P, B, M) indicates that they contained both wild-type and mutant genes. In other words, the mtA3243G mutations all exist in heteroplasmy. The differences in intensity of 111 bp and 87 bp bands between the samples containing A3243G mutations probably reflect the different levels of heteroplasmy. As shown in the Figure 1A , the intensity of 117 bp and 87 bp of the patients is much brighter than that of their brothers, mothers and grandmother, suggesting that the heteroplasmy levels of the patients were higher than those of their family members. All the mtDNA fragments determined to contain A3243G by PCR-RFLP were cloned into pGEM-T vector, followed by DNA sequencing of the recombinant plasmids to reconfirm the mutation. The DNA sequences were then compared to the reference sequence (J01415.2) in the GenBank. The representative homology alignment of the sequence of patient 2 to J01415.2 is presented in Figure 1B . The sequences of PCR products of the patient and his mother had three changes in nucleotides compared to the reference sequence. Of those, two changes in C position 3149 and 3318 were intentionally replaced by T in the designed primers for removing the recognition enzyme site (gray blocks), whereas position 3243 had changed from A to G (red and green blocks). Based on the DNA sequencing data, we can conclude that all patients, their brothers, and mothers have the A3243G mutation.
Taqman LNA real-time PCR assay validation
We further developed a real-time PCR quantification assay with LNA probes to measure the heteroplasmy levels of A3243G mutation. As described in Materials and Methods, we used both LNA and non-LNA probes to compare the sensitivity and reliability of quantification assays in order to choose a suitable one for detecting real samples. First, we wanted to evaluate the allelespecificity of the designed probes. For this purpose, at first, we used mt DNA of three real samples of family 2, which were suggested by the PCR-RFLP data ( Figure 1A , lane 14-16) as a strong positive mutant, weak positive mutant and non-mutant (normal person) for observing the amplification curves. As shown in the Figure 2A1 , 2B1, and 2C1, when using LNA probes, we could observe high curves of HEX in all three samples, a high curve of FAM in the strong positive mutant (A), a low curve in the weak positive mutants (B), and non-detectable FAM signals in the normal sample (C). The data indicate that there was no background of nonspecific FAM signals due to high allele-specificity of the LNA probes. Regarding the non-LNA probes, we also could observe a reduction in amplitude in curves of FAM signals from the strong positive mutant to the low positive mutants ( Figure 2A2 , 2B2), whereas FAM signal was nondetectable in the normal sample ( Figure 2C2) . The HEX signals were also detected clearly in the three samples ( Figure 2A2-2C2) . Taking all the data together, we can conclude that both non-LNA and LNA probes were potentially qualified to detect A3243G mutation. Nevertheless, we needed to know which probes were more sensitive and reliable to quantify the heteroplasmy level. For this purpose, we analyzed standard curves of threshold cycles C t representing FAM signals (Figure 3A1, 3A2 , sky blue lines) and threshold cycles C t representing HEX signals ( Figure 3A1 , 3A2, magenta lines) generated from the individual mutant ( Figure 3A1 , 3A2, sky blue circles) and wild type plasmid standards ( Figure 3A1 , 3A2, magenta circles) at different concentrations ranging from 5 x 10 2 to 5 x 10 7 copies/µl. C t values representing FAM (mutant) and HEX (wild type) signals of sample mixtures carrying mutant genes and wild type genes at different ratios of 0.01%, 0.1%, 1%, 10%, 50%, and 100% mutant were also measured. We could see that in the case of LNA probes, the quantification of mutant and wild-type alleles was equally efficient, as indicated by the similar PCR efficiency and slopes values for both regression lines of FAM signals (sky blue line, PCR efficiency = 97.4; Slope = -3.387) and of HEX signals (magenta line, PCR efficiency = 97.7; Slope = -3.379) ( Figure 3A1 high reliability of the quantification assay. In the case of the sample mixtures, we could clearly detect FAM signals for almost all samples with ratios down to 0.1% mutant. We failed only in the detection of 0.01% mutant (nondetectable FAM signal, data not shown). Based on these data, we built up the regression correlation line between the five measured % mutant values and the expected % mutant values. As presented in the Fig.  3B1 , the correlation line was highly reliable for samples ranging from 0.1% to 100% mutant, with slope of 0.993 and R 2 of 0.998. By contrast, with the non-LNA probes, the quantification of mutant and wild-type alleles was not equally efficient, as indicated by about 10% different PCR efficiency and slope values for regression lines of FAM signals (sky blue line, PCR efficiency = 91.5; Slope = -3.545) and of HEX signals (magenta line, PCR efficiency = 104.6; Slope = -3.215) ( Figure 3A2 ). We calculated the values of R FAM 2 and R HEX 2 to be 0.980 and 0.985, respectively, which were lower than the values obtained with LNA probes. We tried evaluating the sensitivity and reliability of quantification of heteroplasmy levels by using the sample mixtures with different ratios of mutants. Although we could detect FAM signal even in the mixture containing only 0.1% mutant, the measured values of mixtures having low heteroplasmy levels were Figure 3 . Standard curves generated with individual mutants, wild types, and mixtures of mutant and wild type. A1: Standard curves of C t values generated with plasmids containing 100% mutants (sky blue circles and lines) and 100% wild-types (magenta circles and lines) at concentrations ranging from 5 x 10 2 to 5 x 10 7 copies/µl using LNA probes (R FAM 2 = 0.985, R HEX 2 = 0.994) compared to C t values of sample mixtures containing different ratios of 0.1%, 1%, 10%, 50% and 100% mutant (sky blue and magenta ×signals) using the same LNA probes. A2: Standard curves of C t values generated with plasmids containing 100% mutants (sky blue circles and lines) and 100% wild-types (magenta circles and lines) at concentrations ranging from 5 x 10 2 to 5 x 10 7 copies/µl using non-LNA probes (R FAM 2 = 0.98, R HEX 2 = 0.985) compared to C t values of sample mixtures containing different ratios of 0.1%, 1%, 10%, 50% and 100% mutant (sky blue and magenta ×signals) using the same non-LNA probes. B1: Correlation line between the measured % mutant values and expected % mutant values using LNA probe (Slope = 0.993; R 2 = 0.998); B2: Correlation line between the measured % mutant values and expected % mutant values using non-LNA probe (Slope = 0.874; R 2 = 0.950).
not accurate. Specifically, the samples expected to have 0.1%, 1% and 10% mutant actually measured 1.1%, 3.5%, and 31.0%, respectively. As presented in Figure  3B1 , the correlation line between measured % mutant and expected % mutant was unreliable, especially for samples ranging from 0.1% to 10% mutant, with low values of slope = 0.874 and R 2 = 0.95. In addition, the sample in which 100% mutant was expected still had background signal of HEX, resulting in the measured 96% mutant value.
Taking all the data together, we can conclude that LNA probes are more advantageous than non-LNA probes in terms of accurate measurement of wildtype and mutant copies, resulting in high reliability in measurement of the heteroplasmy level. Thus, we chose LNA probes for further real-time quantification of A3243G mutations in real samples.
Quantification of heteroplasmy levels of A3243G
We quantified heteroplasmy levels in 18 samples of five family members in triplicate for each sample. As shown in Figure 4 , we saw that the standard curves representing the five family members were highly reliable, since all had R 2 FAM and R
2 HEX values higher than 0.980. The calculated heteroplasmy levels of 18 members of five families (based on the standard curves) were variable, ranging from 3.68% to 80.85% (Table 2 ). All the patients had higher heteroplasmy values than those of their brothers and mothers. The heteroplasmy levels of their fathers, uncles, and aunts were not detectable, indicating that those family members did not carry the mutation. The results presented in Table 2 correlated well with the change from low to high intensity of 111 bp and 87 bp bands obtained by PCR-RFLP ( Figure 1A ).
Discussion
Singh and his colleagues have applied the real-time PCR method with MGB probes to detect and quantify A3243G. The probes were labeled at the 5' ends with FAM and VIC for mutant and wild type, respectively, and were labeled at the 3' end with MGB for quenching the fluorescent signals and increasing T m of the probes [9] . In the report by Singh et al., the sensitivity of quantification was also 0.1% mutant, which is equal to ours. However, the obtained standard curves for FAM and VIC had R 2 values of only about 0.88 and 0.93, respectively. Meanwhile, we obtained higher R 2 values for FAM (0.985) and HEX (0.994) that validated the method, indicating our quantification method is highly reliable.
The modified oligonucleotides having methyl bridge (or locked) between the 2' oxy and 4' carbon of deoxyribose sugar have interesting properties that not only guarantee their complementary base-pairing but also increase their T m up to about 3 o C to 8 o C per base, compared to non-modified oligonucleotide [14] . In this study, we designed our probes to have "locked" nucleotides at the mutant position and its neighbouring positions. The locked nucleic acid (LNA) probes were only 14 nucleotides long, but their T m was higher than primers, thereby allowing the probes to bind completely to the template at the annealing temperature. Such short-sequence probes, in theory, would help reduce background of FAM or HEX reporter, as the efficiency of quenching is greatly improved when the distance between quencher and reporter is close. In practice, when we used the two LNA probes, the background of nonspecific FAM signal was negligible, and the standard curves of FAM and HEX signals both had high reliability, with R 2 values more than 0.985. The sensitivity and reliability of the real-time PCR with LNA probes was much improved over that of non-LNA probes, as indicated by a highly reliable correlation line (slope = 0.993; R 2 = 0.998) between the expected % mutant and measured % mutant for samples ranging from 0.1% to 100%. Thus, LNA probes could be applied for accurate real-time PCR quantification of heteroplasmy levels, with a sensitivity of 0.1% mutant. We did not use non-LNA probes for quantification of heteroplasmy level, as the reliability of detection was low, as indicated by the correlation line with a slope = 0.874 and R 2 = 0.950. The quantification was especially inaccurate with samples from 0.1% to 10%.
By using the real-time PCR with LNA probes, we were able to detect and quantify exactly the heteroplasmy levels of 18 family members of five patients carrying A3243G mutation. The heteroplasmy levels of positive mutant samples were varied, ranging from 3.68% to 80.85%. The data measured was consistent with the data obtained in PCR-RFLP (Figure 1) . The values of patients were always higher than those of their family members, explaining why their family members did not have clinical symptoms. Based on the data in Table 2 , we can see the clear correlation of heteroplasmy levels to the severity of clinical symptoms in five patients. All five patients had myopathy, which is a common symptom of A3243G-carrying patients. Nevertheless, patient 4 who had the lowest (4.23%) heteroplasmy actually had the fewest symptoms, including seizures and elevated lactate content in plasma. Patients with more than 50% heteroplasmy had a number of additional serious clinical symptoms, especially patient 3, with 80.85% heteroplasmy, who had the most symptoms, including headache, fever, vomiting, brain damage, hearing loss, alogia, and occipital strokes. Surprisingly, the brother of the patient belonging to family 3 was detected to have about 54% heteroplasmy, but he did not show any clinical symptoms. This example shows that the severity of encephalomyopathy does not depend totally on heteroplasmy level, but it is also affected by other unknown factors, which may include nuclear DNA, environment impact, or age.
A greater number of patients and family members will be needed to accurately determine the correlation between % A3243G heteroplasmy and clinical severity.
In summary, this work is the first demonstration of real-time PCR with LNA probes for highly sensitive and reliable quantification of A3243G mitochondrial mutation. Thus, this method could be used as an alternative approach to MGB probes for quantification of other point mutations in human mitochondria. 
